Search Browse Earnings

IRONWOOD PHARMACEUTICALS INC

Nasdaq:IRWD

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company.

Revenue

$74.9M

-81.8% YoY

FY 2025

Adj. EBITDA

$94.3M

126.0% margin

FY 2025

Net Income

-$4.2M

-5.6% margin

FY 2025

EPS (Diluted)

-$0.03

FY 2025

Stock Price

$3.37

-0.3%

2026-03-13

52W Range

$0.53 – $5.78

P/E Ratio

-112.3x

Market Cap

$549.5M

Cash

$88.6M

FY 2025

Total Debt

$443.8M

FY 2022

Net Debt

$355.2M

FY 2022

Enterprise Value

$904.8M

Debt / EBITDA

3.8x

FY 2025

EV / EBITDA

9.6x

Employees

—